Interviews

Cosmo Feilding Mellen on Beckley Psytech’s plans for 2021

Q&A with Beckley Psytech CEO Cosmo Feilding Mellen

Interviews

Enhancing the accessibility of psychedelic healthcare

‘The combination of the drug and psychotherapy is critical. What will be interesting to see is how the healthcare infrastructure reacts to that. That will vary around the world because different healthcare systems are set up differently and mental ... Read More

Interviews

“Unlocking the therapeutic potential of psychedelic medicine is not just a business for us, it is ...

Expert interview with Cosmo Feilding-Mellen on Beckley Psytech’s longstanding involvement in the psychedelic medicine space and best-in-class drug development team.

Interviews

Brunch with Sifted: Amanda Feilding and Cosmo Feilding-Mellen on the psychedelic renaissance

“The logic behind setting up Beckley Psytech was that there’s this body of evidence that’s been generated in an academic setting, in early stage, proof of concept settings. Now the next step is to actually take these drugs through the drug deve... Read More

Interviews

Learning from 50 years of psychedelic progress

Q&A with Beckley Psytech Director & Chair of Scientific Advisory Board, Lady Amanda Feilding. Amanda Feilding has been called the ‘hidden hand’ behind the renaissance of psychedelic science. Her contribution to global drug policy reform and to op... Read More

Interviews

Pushing the frontiers of psychedelic medicine

Q&A with Beckley Psytech CEO Cosmo Feilding-Mellen